Menu
GeneBe

rs2227566

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002658.6(PLAU):​c.681-7C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.521 in 1,610,644 control chromosomes in the GnomAD database, including 228,116 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.50 ( 19388 hom., cov: 32)
Exomes 𝑓: 0.52 ( 208728 hom. )

Consequence

PLAU
NM_002658.6 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00005973
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.341
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
This place is a probable branch point but likely benign (scored 3 / 10). Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 10-73913973-C-T is Benign according to our data. Variant chr10-73913973-C-T is described in ClinVar as [Benign]. Clinvar id is 300752.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-73913973-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.562 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLAUNM_002658.6 linkuse as main transcriptc.681-7C>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000372764.4
C10orf55NR_160938.1 linkuse as main transcriptn.269-898G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLAUENST00000372764.4 linkuse as main transcriptc.681-7C>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_002658.6 P1P00749-1
C10orf55ENST00000409178.5 linkuse as main transcriptn.269-898G>A intron_variant, non_coding_transcript_variant 1
PLAUENST00000446342.5 linkuse as main transcriptc.630-7C>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 2 P00749-2

Frequencies

GnomAD3 genomes
AF:
0.496
AC:
75330
AN:
151952
Hom.:
19381
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.457
Gnomad AMI
AF:
0.501
Gnomad AMR
AF:
0.460
Gnomad ASJ
AF:
0.586
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.295
Gnomad FIN
AF:
0.475
Gnomad MID
AF:
0.595
Gnomad NFE
AF:
0.566
Gnomad OTH
AF:
0.565
GnomAD3 exomes
AF:
0.453
AC:
113615
AN:
251014
Hom.:
29051
AF XY:
0.457
AC XY:
62021
AN XY:
135660
show subpopulations
Gnomad AFR exome
AF:
0.454
Gnomad AMR exome
AF:
0.314
Gnomad ASJ exome
AF:
0.574
Gnomad EAS exome
AF:
0.102
Gnomad SAS exome
AF:
0.305
Gnomad FIN exome
AF:
0.468
Gnomad NFE exome
AF:
0.574
Gnomad OTH exome
AF:
0.516
GnomAD4 exome
AF:
0.523
AC:
763207
AN:
1458574
Hom.:
208728
Cov.:
34
AF XY:
0.519
AC XY:
376794
AN XY:
725790
show subpopulations
Gnomad4 AFR exome
AF:
0.455
Gnomad4 AMR exome
AF:
0.331
Gnomad4 ASJ exome
AF:
0.579
Gnomad4 EAS exome
AF:
0.108
Gnomad4 SAS exome
AF:
0.310
Gnomad4 FIN exome
AF:
0.466
Gnomad4 NFE exome
AF:
0.566
Gnomad4 OTH exome
AF:
0.516
GnomAD4 genome
AF:
0.496
AC:
75363
AN:
152070
Hom.:
19388
Cov.:
32
AF XY:
0.488
AC XY:
36296
AN XY:
74316
show subpopulations
Gnomad4 AFR
AF:
0.457
Gnomad4 AMR
AF:
0.459
Gnomad4 ASJ
AF:
0.586
Gnomad4 EAS
AF:
0.116
Gnomad4 SAS
AF:
0.295
Gnomad4 FIN
AF:
0.475
Gnomad4 NFE
AF:
0.566
Gnomad4 OTH
AF:
0.560
Alfa
AF:
0.561
Hom.:
32305
Bravo
AF:
0.495
Asia WGS
AF:
0.215
AC:
748
AN:
3478
EpiCase
AF:
0.586
EpiControl
AF:
0.597

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Quebec platelet disorder Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 05, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 09, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
8.5
DANN
Benign
0.79
BranchPoint Hunter
3.0

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000060
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2227566; hg19: chr10-75673731; COSMIC: COSV65642067; COSMIC: COSV65642067; API